During the past decade, Allergy & Asthma Associates of Santa Clara Valley Research Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy & Asthma Associates of Santa Clara Valley Research Center" #1 sponsor was "Aimmune Therapeutics, Inc." with 4 trials, followed by "Meda Pharmaceuticals" with 4 trials sponsored, "Novartis" with 2 trials sponsored, "Sunovion" with 2 trials sponsored and "Zosano Pharma Corporation" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy & Asthma Associates of Santa Clara Valley Research Center" #1 collaborator was "Pacira Pharmaceuticals, Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Allergy & Asthma Associates of Santa Clara Valley Research Center" are "Asthma" (7 trials), "Peanut Allergy" (4 trials), "Perennial Allergic Rhinitis" (2 trials), "Acute Migraine" (1 trials) and "Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Allergy & Asthma Associates of Santa Clara Valley Research Center" in a lesser frequency.

Most popular intervention types in "Allergy & Asthma Associates of Santa Clara Valley Research Center" are "Drug" (15 trials), "Biological" (4 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AR101" (3 trials), "0.15% azelastine hydrochloride" (1 trials), "0.15% azelastine hydrochloride Nasal Spray" (1 trials) and "ADX-629" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy & Asthma Associates of Santa Clara Valley Research Center" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Allergy & Asthma Associates of Santa Clara Valley Research Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Allergy & Asthma Associates of Santa Clara Valley Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Allergy & Asthma Associates of Santa Clara Valley Research Center, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".